Performance of CAST (Cellular Antigen Stimulation Test) in Patients With Wasp Venom Allergy: Evaluation of Neutralizing IgG Subclasses
NCT ID: NCT00794287
Last Updated: 2015-06-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2009-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pilot Study: Characterization of the Immune Phenotype of Patients Allergic to Wasp Venom or Penicillin
NCT03219827
Efficacy and Safety of a Purified Standardised Bee Venom Preparation
NCT00263952
The Causative Insects in Severe Insect Sting Allergy
NCT02764242
Study of Autologous Total Immunoglobulin G Therapy for Atopic Dermatitis
NCT02835170
Detection of Aluminium-reactive T-lymphocytes in Patients With Vaccination Granulomas
NCT06130462
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Hymenoptera allergic patients before allergen specific immunotherapy
Taking blood samples
No intervention is done. Only blood samples are taken.
2
Hymenoptera allergic patients after allergen specific immunotherapy
Taking blood samples
No intervention is done. Only blood samples are taken.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Taking blood samples
No intervention is done. Only blood samples are taken.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18-75 years
* planned SIT against wasp venom or finished 5 years SIT against wsp venom (10/10)
Exclusion Criteria
* chromogycin
* ketotifen
* immunosuppressive drugs within the last 2 years
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Zurich
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
01 Studienregister MasterAdmins
Role: STUDY_DIRECTOR
UniversitaetsSpital Zuerich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ZU-AgNT-004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.